Products
| Brand name | Generic name | Product type | Indication | Product Information | Consumer Medicine Information |
|---|---|---|---|---|---|
| AndroForte® 5 | Testosterone | Upper body or scrotal application. | Confirmed testosterone deficiency in men | PI | CMI |
| AndroForte® 2 | Testosterone | Scrotal cream | Confirmed testosterone deficiency in men | PI | CMI |
| AndroFeme® 1 | Testosterone | Topical cream | Hypoactive sexual desire dysfunction (HSDD) in postmenopausal women | PI | CMI |
| ProFeme® 10 | Progesterone | Topical cream | For use in women | PI | CMI |
Using the Dose Applicator Demonstration Video
Latest News
AndroFeme 1 included on ARTG for hypoactive sexual desire dysfunction in postmenopausal women
Lawley Pharmaceuticals’ female-specific hormone cream, AndroFeme® 1, has been registered on the Australian Register of Therapeutic Goods (ARTG) for the treatment of postmenopausal women… Continue Reading →
The Menopause Charity launches in the UK
Menopause specialist Dr Louise Newson has launched a new Crowdfunding campaign for The Menopause Charity, which she hopes will change millions of women’s lives… Continue Reading →
Tanner Pharma Group and Lawley Pharmaceuticals Initiate Global Named Patient Program for AndroFeme® 1
Friday 12th June 2020 Perth, Australia and Charlotte, USA – Lawley Pharmaceuticals and Tanner Pharma Group announced today that they have initiated a global… Continue Reading →